Association of NAT-2 Gene Polymorphisms Toward Lung Cancer Susceptibility and Prognosis in North Indian Patients Treated with Platinum-Based Chemotherapy

References

• Chen HC , CaoYF , HuWXet al. Genetic polymorphisms of phase II metabolic enzymes and lung cancer susceptibility in a population of Central South China. Dis. Markers22(3), 141–152 (2006).
   PubMed Web of Science ®Google Scholar
• Gemignani F , LandiS , Szeszenia-DabrowskaNet al. Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes. Carcinogenesis28(6), 1287–1293 (2007).
   PubMed Web of Science ®Google Scholar
• Mota P , SilvaHC , SoaresMJet al. Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility. J. Cancer Res. Clin. Oncol.141(5), 851–860 (2015).
   PubMed Web of Science ®Google Scholar
• Tian F , ZhangY , RenY , ShenL , WuW , ZhouB. N-Acetyltransferase 2 (NAT2) gene polymorphism and exposure to smoking in lung cancer of Chinese males. Med. Oncol.31(8), 90 (2014).
   PubMed Web of Science ®Google Scholar
• Liu C , CuiW , CongLet al. Association between NAT2 polymorphisms and lung cancer susceptibility. Medicine94(49), e1947 (2015).
   PubMed Web of Science ®Google Scholar
• Borlak J , Reamon-BuettnerSM. N-acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung cancer patients. BMC Med. Genet.7(1), 58 (2006).
   PubMedGoogle Scholar
• Seow A , ZhaoB , PohWTet al. NAT2 slow acetylator genotype is associated with increased risk of lung cancer among non-smoking Chinese women in Singapore. Carcinogenesis20(9), 1877–1881 (1999).
   PubMed Web of Science ®Google Scholar
• Mahasneh A , JubailiA , ElBateiha Aet al. Polymorphisms of arylamine N-acetyltransferase2 and risk of lung and colorectal cancer. Genet. Mol. Biol.35(4), 725–733 (2012).
   PubMed Web of Science ®Google Scholar
• da Silva TD , FelipeAV , de LimaJM , OshimaCTF , ForonesNM. N-Acetyltransferase 2 genetic polymorphisms and risk of colorectal cancer. World J. Gastroenterol.17(6), 760 (2011).
   PubMed Web of Science ®Google Scholar
• Martínez C , AgúndezJA , OliveraM , MartínR , LaderoJM , BenítezJ. Lung cancer and mutations at the polymorphic NAT2 gene locus. Pharmacogenet. Genomics5(4), 207–214 (1995).
   Google Scholar
• Bouchardy C , MitrunenK , WikmanHet al. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk. Pharmacogenetics8(4), 291–298 (1998).
   PubMedGoogle Scholar
• Saarikoski ST , ReinikainenM , AnttilaSet al. Role of NAT2 deficiency in susceptibility to lung cancer among asbestos-exposed individuals. Pharmacogenet. Genomics10(2), 183–185 (2000).
   Google Scholar
• Cascorbi I , BrockmöllerJ , MrozikiewizPM , BauerS , LoddenkemperR , RootsI. Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer. Cancer Res.56(17), 3961–3966 (1996).
   PubMed Web of Science ®Google Scholar
• Oyama T , KawamotoT , MizoueT , YasumotoK , KodamaY , MitsudomiT. N-acetylation polymorphism in patients with lung cancer and its association with p53 gene mutation. Anticancer Res.17(1B), 577–581 (1997).
   PubMed Web of Science ®Google Scholar
• Hou SM , RybergD , FältSet al. GSTM1 and NAT2 polymorphisms in operable and non-operable lung cancer patients. Carcinogenesis21(1), 49–54 (2000).
   PubMed Web of Science ®Google Scholar
• Cui D , WangZ , ZhaoE , MaJ , LuW. NAT2 polymorphism and lung cancer risk: a meta-analysis. Lung Cancer73(2), 153–157 (2011).
   PubMed Web of Science ®Google Scholar
• Sobti RC , KaurP , KaurSet al. Impact of interaction of polymorphic forms of p53 codon 72 and N-acetylation gene (NAT2) on the risk of lung cancer in the North Indian population. DNA Cell Biol.28(9), 443–449 (2009).
   PubMed Web of Science ®Google Scholar
• Bahl C , SharmaS , SinghN , BeheraD. Association study between genetic variations in Axin2 gene and lung cancer risk in North Indian population: a multiple interaction analysis. Tumor Biol.39(4), 1–18 (2017).
   Google Scholar
• Smith CA , WadeliusM , GoughAC , HarrisonDJ , WolfCR , RaneA. A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid. J. Med. Genet.34(9), 758–760 (1997).
   PubMed Web of Science ®Google Scholar
• Lotfi F , BahrehmandF , Vaisi-RayganiAet al. Cytochrome P450 (CYP450, 2D6* A), N-acetyltransferase-2 (NAT2* 7, A) and multidrug resistance 1 (MDR1 3435 T) alleles collectively increase risk of ulcerative colitis. Arch. Iran. Med.21(11), 530–535 (2018).
   PubMed Web of Science ®Google Scholar
• Lee CN , YuMC , BaiKJet al. NAT2 fast acetylator genotypes are associated with an increased risk for lung cancer with wildtype epidermal growth factor receptors in Taiwan. Lung Cancer64(1), 9–12 (2009).
   PubMed Web of Science ®Google Scholar
• Hansen JL , SchmeingTM , KleinDJet al. Progress toward an understanding of the structure and enzymatic mechanism of the large ribosomal subunit. Cold Spring Harb. Symp. Quant. Biol.66, 33–42 (2001).
   PubMedGoogle Scholar
• Zhou W , LiuG , ThurstonSWet al. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer. Cancer Epidemiol. Biomark. Prev.11(1), 15–21 (2002).
   PubMed Web of Science ®Google Scholar
• Perera FP , TangD , Brandt-RaufPet al. Lack of associations between cancer and albumin adducts, ras p21 oncoprotein levels, and CYP1A1, CYP2D6, NAT1, NAT2 in a nested case-control study of lung cancer within the Physicians Health Study. Cancer Epidemiol. Biomark. Prev.15(7), 1417 (2006).
   PubMed Web of Science ®Google Scholar
• Wikman H , ThielS , JägerBet al. Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility. Pharmacogenet. Genomics11(2), 157–168 (2001).
   Google Scholar
• Rusinova GG , AzizovaTV , ViazovskaiaNS , GlazkovaIV , OsovetsSV. Role of gene polymorphisms of phase II of xenobiotic biotransformation from glutathione-S-transferase and N-acetyltransferase families in susceptibility to lung cancer among Mayak workers. Radiatsionnaia Biologiia Radioecologiia.54(4), 350–359 (2014).
   PubMedGoogle Scholar
• Zhu K , XuA , ZhangBet al. Effects of NAT2 polymorphism on lung cancer risk, and the interaction between smoking and NAT2: a meta-analysis (2020). https://www.researchsquare.com/article/rs-39646/v1
   Google Scholar
• Duval R , XuX , BuiLCet al. Identification of cancer chemopreventive isothiocyanates as direct inhibitors of the arylamine N-acetyltransferase-dependent acetylation and bioactivation of aromatic amine carcinogens. Oncotarget7(8), 8688 (2016).
   PubMedGoogle Scholar
• McKay JD , HashibeM , HungRJet al. Sequence variants of NAT1 and NAT2 and other xenometabolic genes and risk of lung and aerodigestive tract cancers in Central Europe. Cancer Epidemiol. Biomark. Prev.17(1), 141–147 (2008).
   PubMed Web of Science ®Google Scholar
• Seow A , ZhaoB , LeeEJet al. Cytochrome P4501A2 (CYP1A2) activity and lung cancer risk: a preliminary study among Chinese women in Singapore. Carcinogenesis22(4), 673–677 (2001).
   PubMed Web of Science ®Google Scholar
• Habalova V , SalagovicJ , KalinaI , StubnaJ. A pilot study testing the genetic polymorphism of N-acetyltransferase 2 as a risk factor in lung cancer. Neoplasma52(5), 364–368 (2005).
   PubMed Web of Science ®Google Scholar
• Zienolddiny S , CampaD , LindHet al. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers. Carcinogenesis29(6), 1164–1169 (2008).
   PubMed Web of Science ®Google Scholar
• Skuladottir H , AutrupH , AutrupJet al. Polymorphisms in genes involved in xenobiotic metabolism and lung cancer risk under the age of 60 years: a pooled study of lung cancer patients in Denmark and Norway. Lung Cancer48(2), 187–199 (2005).
   PubMed Web of Science ®Google Scholar
• Chiou HL , WuMF , ChienWPet al. NAT2 fast acetylator genotype is associated with an increased risk of lung cancer among never-smoking women in Taiwan. Cancer Lett.223(1), 93–101 (2005).
   PubMed Web of Science ®Google Scholar
• Zhu K , XuA , XiaWet al. Association between NAT2 polymorphism and lung cancer risk: a systematic review and meta-analysis. Front. Oncol.11 (2021).
   Google Scholar
• Sørensen M , AutrupH , TjønnelandA , OvervadK , Raaschou-NielsenO. Genetic polymorphisms in CYP1B1, GSTA1, NQO1 and NAT2 and the risk of lung cancer. Cancer Lett.221(2), 185–190 (2005).
   PubMed Web of Science ®Google Scholar
• Osawa Y , OsawaK , MiyaishiAet al. NAT2 and CYP1A2 Polymorphisms and Lung Cancer Risk in Relation to Smoking Status. Asian Pac. J. Cancer Prev.8(1), 103–108 (2007).
   PubMedGoogle Scholar
• Nyberg F , HouSM , HemminkiK , LambertB , PershagenG. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls. Cancer Epidemiol. Biomark. Prev.7(10), 875–883 (1998).
   PubMed Web of Science ®Google Scholar
• Zhang JW , YuWJ , ShengXMet al. Association of CYP2E1 and NAT2 polymorphisms with lung cancer susceptibility among Mongolian and Han populations in the Inner Mongolian region. Asian Pac. J Cancer Prev.15(21), 9203–9210 (2014).
   PubMedGoogle Scholar
• Hunter DJ , HankinsonSE , HoughHet al. A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer. Carcinogenesis18(11), 2127–2132 (1997).
   PubMed Web of Science ®Google Scholar